Moxon et al. - Google Patents
Development, Characterization, andMoxon et al.
- Document ID
- 14035263228358009860
- Author
- Moxon R
- Richards J
External Links
- 238000011161 development 0 title abstract description 9
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Plested et al. | Conservation and accessibility of an inner core lipopolysaccharide epitope of Neisseria meningitidis | |
| Ala'Aldeen et al. | Immune responses in humans and animals to meningococcal transferrin-binding proteins: implications for vaccine design | |
| EP2265640B1 (en) | Chimeric factor h binding proteins (fhbp) containing a heterologous b domain and methods of use | |
| Moran et al. | Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity | |
| US20090285845A1 (en) | Domains And Epitopes Of Meningococcal Protein NMB1870 | |
| Moe et al. | Sequential immunization with vesicles prepared from heterologous Neisseria meningitidis strains elicits broadly protective serum antibodies to group B strains | |
| US8148499B2 (en) | Vaccine | |
| Bernfield et al. | Identification of a novel vaccine candidate for group B Neisseria meningitidis | |
| Gidney et al. | Development, characterization, and functional activity of a panel of specific monoclonal antibodies to inner core lipopolysaccharide epitopes in Neisseria meningitidis | |
| Maskell et al. | The gal locus from Haemophilus influenzae: cloning, sequencing and the use of gal mutants to study lipopolysaccharide | |
| Dutta Ray et al. | Novel blocking human IgG directed against the pentapeptide repeat motifs of Neisseria meningitidis Lip/H. 8 and Laz lipoproteins | |
| Zollinger et al. | Meningococcal vaccines—present and future | |
| US7537766B2 (en) | Neisseria meningitidis inner core lipo-oligosaccharide epitopes, multivalent conjugates thereof and immunogenic compositions thereof | |
| Plested et al. | Enzyme linked immunosorbent assay (ELISA) for the detection of serum antibodies to the inner core lipopolysaccharide of Neisseria meningitidis group B | |
| Jäkel et al. | Naturally-occurring human serum antibodies to inner core lipopolysaccharide epitopes of Neisseria meningitidis protect against invasive meningococcal disease caused by isolates displaying homologous inner core structures | |
| Moxon et al. | Development, Characterization, and | |
| Tunheim et al. | Preclinical immunogenicity study of trivalent meningococcal AWX-OMV vaccines for the African meningitis belt | |
| Kortekaas et al. | Shielding of immunogenic domains in Neisseria meningitidis FrpB (FetA) by the major variable region | |
| Andersen et al. | Outer membrane vesicle vaccines made from short-chain lipopolysaccharide mutants of serogroup B Neisseria meningitidis: effect of the carbohydrate chain length on the immune response | |
| Tzitzilonis et al. | Structural variation and immune recognition of the P1. 2 subtype meningococcal antigen | |
| Tzitzilonis | Structural studies of outer membrane proteins from Neisseria Meningitidis | |
| WO2015017823A1 (en) | Tetravalent pneumococcal serogroup 6z | |
| Gulati | Anti-idiotope antibody as a surrogate vaccine immunogen for lipooligosaccharide (LOS) of Neisseria gonorrhoeae | |
| Chalmers et al. | Phosphoethanolamine to Inner-Core | |
| Telford et al. | Reverse vaccinology: From genome to vaccine |